Veerenni Apteek OÜ

14767320

Company info

Veerenni Apteek OÜ

14767320

Kõik ravimid Südameapteegi e-apteegisthttps://sydameapteek.eeKõik ravimid Südameapteegi e-apteegist

Südameapteegi e-apteek: telli mugavalt ravimid, toidulisandid, vitamiinid ja apteegikosmeetika pakiautomaati, apteeki või koju. Tarne alates 0 eurot.

General info

Name

Veerenni Apteek OÜ

Registry code

14767320

VAT number

EE102183414

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

24.07.2019 (5)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

47731 - Dispensing chemist in specialised stores

Revenue

9 379 643 €

Profit

42 381 €

Profit margin

0%

Gross salary

-

Equity

320 277 €

Employees

22

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

13%

Return on assets

2%

Related parties

Owner Representative Beneficial owner Roles

Ene Bötker

23.02.1962 (62)

100% - 2 500.00 EUR Board member Direct ownership Founder

Financial info

2020
30.06.2021
2021
30.06.2022
2022
30.06.2023
2023
30.06.2024
Total Revenue 6 030 949 € 6 331 187 € 8 753 026 € 9 379 643 €
Net profit (loss) for the period 5 686 € 112 843 € 159 367 € 42 381 €
Profit Margin 0% 2% 2% 0%
Current Assets 937 058 € 1 200 607 € 2 029 987 € 2 131 191 €
Fixed Assets 200 000 € 200 000 € 201 134 € 208 542 €
Total Assets 1 137 058 € 1 400 607 € 2 231 121 € 2 339 733 €
Current Liabilities 1 131 372 € 1 282 078 € 1 953 225 € 2 019 456 €
Non Current Liabilities - - - -
Total Liabilities - - - -
Share Capital - - - -
Equity 5 686 € 118 529 € 277 896 € 320 277 €
Employees 23 22 23 22

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 2 911 306.5 € 78 602.42 € 86 761.32 € 24
2023 Q4 2 914 593.99 € 85 707.77 € 72 040.47 € 26
2023 Q3 2 411 623.42 € 90 792 € 82 888.96 € 25
2023 Q2 2 871 376.59 € 82 124.72 € 65 769.66 € 26
2023 Q1 2 494 756.82 € 86 684.7 € 79 888.21 € 25
2022 Q4 2 821 090.04 € 95 199.07 € 68 896.62 € 26
2022 Q3 2 180 213.6 € 84 165.61 € 78 113.33 € 26
2022 Q2 2 391 076.52 € 103 858.97 € 80 092.45 € 26
2022 Q1 2 105 453.46 € 105 133.66 € 85 751.2 € 29
2021 Q4 2 012 794.67 € 107 740 € 72 009.31 € 31
2021 Q3 1 683 048.96 € 92 819.44 € 71 484.74 € 28
2021 Q2 1 952 665.26 € 93 091.1 € 64 234.48 € 28
2021 Q1 1 679 825.27 € 102 921.2 € 71 599.71 € 27
2020 Q4 1 741 964.6 € 70 496.42 € 63 884.7 € 28
2020 Q3 1 435 103.39 € 63 643.71 € 63 798.81 € 26
2020 Q2 1 635 086.71 € 71 192.3 € 62 479.68 € 28
2020 Q1 672 790.63 € 59 789.07 € 47 055.33 € 28